United Therapeutics Corporation
Symbol: UTHR
NASDAQ
258.13
USDMarktpreis heute
11.5489
P/E-Verhältnis
-0.0982
PEG-Verhältnis
11.45B
MRK Kapital
- 0.00%
DIV Rendite
United Therapeutics Corporation (UTHR) Finanzberichte
Bilanz
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 13884.5 | 2994.1 | 4154.9 | 3580.6 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-investments | 9250.3 | 1786.4 | 1877.5 | 1035.9 | ||||||||||||||||||||||||||
balance-sheet.row.net-receivables | 1117.5 | 278.9 | 220.4 | 198.7 | ||||||||||||||||||||||||||
balance-sheet.row.inventory | 439.6 | 111.8 | 102 | 93.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-current-assets | 5494.3 | 166.2 | 219.2 | 100.4 | ||||||||||||||||||||||||||
balance-sheet.row.total-current-assets | 13472 | 3551 | 3380.3 | 2323.6 | ||||||||||||||||||||||||||
balance-sheet.row.property-plant-equipment-net | 4050.5 | 1045.4 | 861.5 | 780.9 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill | 33.7 | 33.7 | 28 | 28 | ||||||||||||||||||||||||||
balance-sheet.row.intangible-assets | 169.4 | 80.5 | 16.5 | 16.6 | ||||||||||||||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 318.5 | 114.2 | 44.5 | 44.6 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-investments | 7486.1 | 1909.8 | 1316.2 | 1649.9 | ||||||||||||||||||||||||||
balance-sheet.row.tax-assets | 1442.1 | 394.8 | 327.7 | 261.9 | ||||||||||||||||||||||||||
balance-sheet.row.other-non-current-assets | 597.9 | 151.8 | 114.3 | 108.2 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-assets | 13895.1 | 3616 | 2664.2 | 2845.5 | ||||||||||||||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-assets | 27367.1 | 7167 | 6044.5 | 5169.1 | ||||||||||||||||||||||||||
balance-sheet.row.account-payables | 631 | 5.6 | 4.1 | 3.8 | ||||||||||||||||||||||||||
balance-sheet.row.short-term-debt | 700 | 400 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.tax-payables | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.long-term-debt-total | 1800 | 300 | 800 | 800 | ||||||||||||||||||||||||||
Deferred Revenue Non Current | -42.4 | -42.4 | -41 | -30 | ||||||||||||||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 42.4 | - | - | - | ||||||||||||||||||||||||||
balance-sheet.row.other-current-liab | 1454 | 71 | 339.1 | 301.6 | ||||||||||||||||||||||||||
balance-sheet.row.total-non-current-liabilities | 2141.7 | 377.8 | 904.6 | 904.8 | ||||||||||||||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.capital-lease-obligations | 32.8 | 32.8 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-liab | 4921.1 | 1182.2 | 1247.8 | 1210.2 | ||||||||||||||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.common-stock | 2.8 | 0.7 | 0.7 | 0.7 | ||||||||||||||||||||||||||
balance-sheet.row.retained-earnings | 23713.2 | 6027.1 | 5042.3 | 4315 | ||||||||||||||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | -122.7 | -12.8 | -55.5 | -23 | ||||||||||||||||||||||||||
balance-sheet.row.other-total-stockholders-equity | -1147.3 | -30.2 | -190.8 | -333.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-stockholders-equity | 22446 | 5984.8 | 4796.7 | 3958.9 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 27367.1 | 7167 | 6044.5 | 5169.1 | ||||||||||||||||||||||||||
balance-sheet.row.minority-interest | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
balance-sheet.row.total-equity | 22446 | 5984.8 | 4796.7 | 3958.9 | ||||||||||||||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 27367.1 | - | - | - | ||||||||||||||||||||||||||
Total Investments | 9272.5 | 3696.2 | 3193.7 | 2685.8 | ||||||||||||||||||||||||||
balance-sheet.row.total-debt | 2200 | 700 | 800 | 800 | ||||||||||||||||||||||||||
balance-sheet.row.net-debt | -2434.2 | -507.7 | -161.2 | -94.8 |
Kapitalflussrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 1050.5 | 984.8 | 727.3 | 475.8 | ||||||||||||||||||||||||||
cash-flows.row.depreciation-and-amortization | 54.9 | 53.2 | 51.3 | 49.9 | ||||||||||||||||||||||||||
cash-flows.row.deferred-income-tax | 71 | 3.6 | -71.7 | -89.7 | ||||||||||||||||||||||||||
cash-flows.row.stock-based-compensation | 51.5 | 39.1 | 106.8 | 138.5 | ||||||||||||||||||||||||||
cash-flows.row.change-in-working-capital | -219.9 | -97.8 | -35.1 | -48.8 | ||||||||||||||||||||||||||
cash-flows.row.account-receivables | -172.7 | -58.5 | -21.7 | -41.3 | ||||||||||||||||||||||||||
cash-flows.row.inventory | -20.4 | -13.6 | -13.4 | -7.5 | ||||||||||||||||||||||||||
cash-flows.row.account-payables | 61.3 | 57.1 | 150.6 | 112.9 | ||||||||||||||||||||||||||
cash-flows.row.other-working-capital | -123.8 | -82.8 | -150.6 | -112.9 | ||||||||||||||||||||||||||
cash-flows.row.other-non-cash-items | -313.1 | -4.9 | 23.9 | 72.5 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | 979.7 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -227.3 | -230.4 | -138.8 | -120.8 | ||||||||||||||||||||||||||
cash-flows.row.acquisitions-net | 326.7 | -89.2 | 7.1 | 366.1 | ||||||||||||||||||||||||||
cash-flows.row.purchases-of-investments | -2154.1 | -2514.3 | -1708.6 | -1895.3 | ||||||||||||||||||||||||||
cash-flows.row.sales-maturities-of-investments | 1902.9 | 2137.3 | 1025.3 | 1529.2 | ||||||||||||||||||||||||||
cash-flows.row.other-investing-activites | 388.6 | -23 | 3.5 | -366.1 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 236.8 | -719.6 | -811.5 | -486.9 | ||||||||||||||||||||||||||
cash-flows.row.debt-repayment | -100 | -100 | -800 | 0 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-issued | 43.7 | 6.6 | 94.3 | 55.6 | ||||||||||||||||||||||||||
cash-flows.row.common-stock-repurchased | -1000.3 | -13.8 | -11.4 | -10.8 | ||||||||||||||||||||||||||
cash-flows.row.dividends-paid | 0 | -98 | -94.3 | 0 | ||||||||||||||||||||||||||
cash-flows.row.other-financing-activites | -40.1 | 193.3 | 886.8 | -10.8 | ||||||||||||||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -1128.5 | -11.9 | 75.4 | 44.8 | ||||||||||||||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
cash-flows.row.net-change-in-cash | 88 | 246.5 | 66.4 | 156.1 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-end-of-period | 4634.2 | 1207.7 | 961.2 | 894.8 | ||||||||||||||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4546.2 | 961.2 | 894.8 | 738.7 | ||||||||||||||||||||||||||
cash-flows.row.operating-cash-flow | 979.7 | 978 | 802.5 | 598.2 | ||||||||||||||||||||||||||
cash-flows.row.capital-expenditure | -227.3 | -230.4 | -138.8 | -120.8 | ||||||||||||||||||||||||||
cash-flows.row.free-cash-flow | 752.4 | 747.6 | 663.7 | 477.4 |
Zeile der Gewinn- und Verlustrechnung
common:word.in-mln USD Growth | TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 2498.3 | 2327.5 | 1936.3 | 1685.5 | ||||||||||||||||||||||||||
income-statement-row.row.cost-of-revenue | 278.1 | 257.5 | 146.7 | 122.5 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit | 2220.2 | 2070 | 1789.6 | 1563 | ||||||||||||||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | ||||||||||||||||||||||||||
income-statement-row.row.research-development | 429.2 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-general-administrative | 324.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 64.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-expenses | -6.1 | -14 | -40.2 | 42.2 | ||||||||||||||||||||||||||
income-statement-row.row.operating-expenses | 961.6 | 885.1 | 809.9 | 1007.1 | ||||||||||||||||||||||||||
income-statement-row.row.cost-and-expenses | 1239.7 | 1142.6 | 956.6 | 1129.6 | ||||||||||||||||||||||||||
income-statement-row.row.interest-income | 187.3 | 162.7 | 45.2 | 16.7 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 32.2 | 59.3 | 32.4 | 18.6 | ||||||||||||||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 64.9 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.total-other-income-expensenet | 36.2 | -14 | -29.1 | 38 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.other-operating-expenses | -6.1 | -14 | -40.2 | 42.2 | ||||||||||||||||||||||||||
income-statement-row.row.total-operating-expenses | 36.2 | -14 | -29.1 | 38 | ||||||||||||||||||||||||||
income-statement-row.row.interest-expense | 32.2 | 59.3 | 32.4 | 18.6 | ||||||||||||||||||||||||||
income-statement-row.row.depreciation-and-amortization | 104 | 53.2 | 5 | 58.9 | ||||||||||||||||||||||||||
income-statement-row.row.ebitda-caps | 1411.2 | - | - | - | ||||||||||||||||||||||||||
income-statement-row.row.operating-income | 1256.8 | 1184.9 | 979.7 | 555.9 | ||||||||||||||||||||||||||
income-statement-row.row.income-before-tax | 1381 | 1274.3 | 950.6 | 593.9 | ||||||||||||||||||||||||||
income-statement-row.row.income-tax-expense | 330.5 | 289.5 | 223.3 | 118.1 | ||||||||||||||||||||||||||
income-statement-row.row.net-income | 1050.5 | 984.8 | 727.3 | 475.8 |
Häufig gestellte Frage
Wie hoch ist die United Therapeutics Corporation (UTHR) Gesamtvermögen?
United Therapeutics Corporation (UTHR) Gesamtvermögen ist 7167000000.000.
Wie hoch ist der Jahresumsatz des Unternehmens?
Der Jahresumsatz ist 1292400000.000.
Wie hoch ist die Gewinnspanne des Unternehmens?
Die Gewinnmarge des Unternehmens ist 0.889.
Wie hoch ist der freie Cashflow des Unternehmens?
Der freie Cashflow ist 16.009.
Wie hoch ist die Nettogewinnspanne des Unternehmens?
Die Nettogewinnmarge ist 0.420.
Wie hoch sind die Gesamteinnahmen des Unternehmens?
Der Gesamtertrag ist 0.503.
Was ist der United Therapeutics Corporation (UTHR) nettogewinn (reingewinn)?
Der Nettogewinn (Nettoeinkommen) ist 984800000.000.
Wie hoch ist die Gesamtverschuldung des Unternehmens?
Die Gesamtverschuldung ist 700000000.000.
Wie hoch ist der Betriebsaufwand?
Die Betriebsausgaben sind 885100000.000.
Wie hoch ist der Bargeldbestand des Unternehmens?
Die Unternehmensliquidität ist 1251500000.000.